Clinical Trials Browser

Phase 2 × UNKNOWN × Pemetrexed × Clear all

NCT02829008 2016-07-12

Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients

Phase 2 Unknown

Breast Neoplasms